Apogee Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apogee Therapeutics by Credit Suisse
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.2M | 18k | 66.45 |
2023-12-31 | $412k | 15k | 27.94 |